Effect of chidamide on treating hepatosplenic T-cell lymphoma: A case report

BACKGROUND: Hepatosplenic T-cell lymphoma (HSTCL) is a rare subtype of non-Hodgkin’s lymphoma, which has an aggressive clinical course and an extremely poor prognosis. Chidamide is a novel, orally active, benzamide-type histone deacetylase (HDAC) inhibitor that has been used for peripheral T-cell ly...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:World J Clin Cases
Hlavní autoři: Wang, Xing-Tong, Guo, Wei, Sun, Mo, Han, Wei, Du, Zhong-Hua, Wang, Xiu-Xiu, Du, Bei-Bei, Bai, Ou
Médium: Artigo
Jazyk:Inglês
Vydáno: Baishideng Publishing Group Inc 2020
Témata:
Case Report
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7385602/
https://ncbi.nlm.nih.gov/pubmed/32775395
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12998/wjcc.v8.i14.3122
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky